ANDHealth to host ACTIVATE program to showcase to strengthen digital health collaboration
Posted: 18 November 2025 ANDHealth will be hosting a major showcase and networking event to present the 2025 ACTIVATE accelerator cohort, bringing Victoria’s digital and connected health ecosystem together for a structured morning of collaboration. The event is…
RMIT University unveils promising blood test to more accurately guide Ovarian Cancer treatment
Posted: 14 November 2025 A new blood test designed to better guide ovarian cancer therapy was reported to have shown strong promise, after researchers identified a simple way to determine which women were more likely to benefit from…
MTPConnect secures Australian representation on global WHO AMR task force
Posted: 14 November 2025 MTPConnect was positioned at the forefront of international antimicrobial resistance (AMR) advocacy, following the selection of its Australian Antimicrobial Resistance Network (AAMRNet) to join the World Health Organization (WHO) Civil Society Task Force on…
Lindo awarded $2 million grant to advance infection-prevention medical device
Posted: 13 November 2025 Lindo has been awarded $2 million in matched funding through the Australian Government’s Industry Growth Programme, enabling progress on its antimicrobial blue-light endotracheal device. “Collaborations like this are essential for translating innovation into practical…
Biointelect Venturer to launch to drive vaccine and infectious disease innovation
Posted: 11 November 2025 Australia’s new national incubator for vaccine and infectious disease innovation, Biointelect Venturer, will officially launch on 17 November 2025, backed by $32.9 million in funding from the Australian Government’s Medical Research Future Fund (MRFF)…
Noxopharm awarded NSW Government TechVoucher grant for UNSW collaboration
Posted: 11 November 2025 Clinical-stage biotechnology company Noxopharm Limited has been awarded a $25,000 NSW Government TechVoucher grant to support a joint research project with UNSW Sydney exploring the potential of its Sofra™ technology platform. The TechVouchers program…
Australian Red Cross Lifeblood launches Circularity Challenge to tackle medical waste
Posted: 11 November 2025 Australian Red Cross Lifeblood has launched its Lifeblood Circularity Challenge, an open innovation initiative seeking creative, scalable solutions to reduce the environmental impact of single-use plastics in healthcare. The challenge calls for ideas that…
Monash and Melbourne researchers uncover mechanism enabling viruses to commandeer human cells
Posted: 7 November 2025 A research team led by Monash University and the University of Melbourne has revealed how small but deadly viruses, such as rabies, manipulate human cells using only a handful of proteins — a discovery…
WEHI led clinical trial receives $1.49 million to test accelerated brain cancer treatment
Posted: 7 November 2025 A new national clinical trial led by the Walter and Eliza Hall Institute of Medical Research (WEHI) has been launched to investigate a faster and less burdensome treatment for people with glioblastoma, the most…
BioMelbourne Network leadership update
Posted: 7 November 2025 The Board of BioMelbourne Network acknowledges the resignation of CEO Karen Parr, effective as of 14 November 2025. We thank Karen for her service. Reflecting on her time with the Network, Karen said: ‘It…
PureCDM appoints Michael Fitzgerald as Director of Biostatistics for Asia-Pacific
Posted: 6 November 2025 PureCDM has announced the appointment of Michael Fitzgerald as Director of Biostatistics for the Asia-Pacific region, marking a key milestone in the company’s continued investment in biostatistical leadership and scientific excellence. With more than…
Noxopharm advances to second phase of HERACLES clinical trial
Posted: 6 November 2025 Noxopharm Limited announced it had commenced the second part of its HERACLES clinical trial, following the successful completion of single-dose testing of its novel autoimmune therapy candidate, SOF-SKN™. Chief Executive Officer Dr Gisela Mautner…
